Sam Miller

Sam Miller

Auto-generated profile, based on publicly available information

Sam Miller

Portsmouth Hospitals NHS Trust at the time of writing

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMuzaffer Kaser
Muzaffer Kaser
FSFruzsina Soltesz
Fruzsina Soltesz
PLPhil Lawrence
Phil Lawrence
SMSam Miller
Sam Miller
CDChris Dodds
Chris Dodds
PNPradeep J. Nathan
Pradeep J. Nathan
Impairments in mismatch negativity (MMN) generation have been consistently reported in patients with schizophrenia. However, underlying oscillatory activity of MMN deficits in schizophrenia and the relationship with cognitive impairments have not been investigated in detail. Time-frequency power and phase analyses can provide more detailed measures of brain dynamics of MMN deficits in schizophrenia. 21 patients with schizophrenia and 21 healthy controls were tested with a roving frequency paradigm to generate MMN. Time-frequency domain power and phase-locking (PL) analysis was performed on all trials using short-time Fourier transforms with Hanning window tapering. A comprehensive battery (CANTAB) was used to assess neurocognitive functioning. Mean MMN amplitude was significantly lower in patients with schizophrenia (95% CI 0.18 - 0.77). Patients showed significantly lower EEG power (95% CI -1.02 - -0.014) in the ~4-7 Hz frequency range (theta band) between 170 and 210 ms. Patients with schizophrenia showed cognitive impairment in multiple domains of CANTAB. However, MMN impairments in amplitude and power were not correlated with clinical measures, medication dose, social functioning or neurocognitive performance. The findings from this study suggested that while MMN may be a useful marker to probe NMDA receptor mediated mechanisms and associated impairments in gain control and perceptual changes, it may not be a useful marker in association with clinical or cognitive changes. Trial-by-trial EEG power analysis can be used as a measure of brain dynamics underlying MMN deficits which also can have implications for the use of MMN as a biomarker for drug discovery.

28 August 2014 in Nursing Management
Verified
Journal Article
Closed access
SMSam Miller
Sam Miller
JBJim Bird
Jim Bird
The Department of Health has tasked Health Education England with introducing values-based recruitment (VBR) for all applicants to NHS-funded healthcare programmes. This article discusses the mandate with reference to the process of VBR, how this is used in an academic setting and how it is beginning to influence appointments to all healthcare posts. The benefits and potential risks of adopting the approach are identified and recommendations for nurse managers are made.